United States · Platforms & data · The Motley Fool

Eli Lilly Just Raised Its 2026 Sales Forecast to as Much as $92 Billion. But Is Viking Therapeutics the Next Big Obesity Winner?

Published by The Motley Fool · United States 54 min ago

Eli Lilly Just Raised Its 2026 Sales Forecast to as Much as $92 Billion. But Is Viking Therapeutics the Next Big Obesity Winner? — Eli Lilly Just Raised Its 2026 Sales Forecast to as Much as $92 Billion. But Is Viking Therapeutics the Next Big Obesity Winner? · The Motley Fool

Detailed summary

These drugmakers offer very different risk-reward profiles.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Nvidia’s stock drops as the board reportedly prepares to remove CEO Jensen Huang

Here are the major earnings before the open Thursday

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (NASDAQ:XNDU) Issues Quarterly Earnings Results

Oil prices rise amid mixed messaging on Iran peace efforts, Hormuz ship attacks

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030